UCB - 운영 비용





운영 비용 변화 날짜
Alcon AG USD 2.78B 370M 2026-06
Almirall EUR 531.16M 13.76M 2026-06
Amarin USD 51.48M 113K 2025-12
argenx SE USD 1.24B 213M 2026-09
AstraZeneca USD 11.55B 674M 2026-09
Bayer EUR 10.04B 168M 2026-06
Genmab DKK 748M 77M 2026-06
GlaxoSmithKline GBP 6.03B 227M 2026-09
GRIFOLS EUR 1.55B 94M 2026-06
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Lakefront Biotherapeutics EUR 55.62M 14.56M 2026-06
Lonza CHF 2.9B 184M 2025-06
Merck EUR 4.34B 249M 2026-06
Novartis USD 9.88B 325M 2026-09
Orion EUR 332.3M 12.7M 2026-09
Recordati EUR 493.59M 11.28M 2026-06
Roche Holding CHF 18.9B 2.12B 2026-06
Sanofi EUR 10.51B 598M 2026-09
UCB EUR 2.96B 196M 2025-12
Unibail Rodamco EUR 646.6M 25.4M 2025-12